Goepfert, Paul A <br/><br/>
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.  [electronic resource] 

 -  The Journal of infectious diseases  Oct 2005 
 - 1249-59 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/432915  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--administration & dosage<br/>Double-Blind Method<br/>Female<br/>HIV Antibodies--blood<br/>HIV Seronegativity--immunology<br/>HIV-1--immunology<br/>Humans<br/>Interferon-gamma--metabolism<br/>Male<br/>Recombinant Proteins--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Treatment Outcome<br/>Vaccination<br/>Vaccines, Synthetic--administration & dosage<br/>Viral Proteins--genetics